Effect of a MUC5AC Antibody (NPC-1C) Administered with Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients with Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial
- Brandon M. Huffman
- , Atrayee Basu Mallick
- , Nora K. Horick
- , Andrea Wang-Gillam
- , Peter Joel Hosein
- , Michael A. Morse
- , Muhammad Shaalan Beg
- , Janet E. Murphy
- , Sharon Mavroukakis
- , Anjum Zaki
- , Benjamin L. Schlechter
- , Hanna Sanoff
- , Christopher Manz
- , Brian M. Wolpin
- , Philip Arlen
- , Jill Lacy
- , James M. Cleary
Research output: Contribution to journal › Article › peer-review
23
Link opens in a new tab
Scopus
citations